Where Neurofilament Light Chain (NfL) is reported
Also listed as: Axonal damage; Axonal damage marker; Neurofilament light chain (NfL)
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Alzheimer's Disease and Other Dementias | ↑ elevated | AD vs healthy/non-AD (core CSF biomarker) | — | Abukuri et al. 2024 |
| Epilepsy | ↕ inconsistent | patients with idiopathic epilepsy (IE) | structural brain diseases (MUE, hydrocephalus, brain tumors) vs IE | Sung et al. 2024 |
| Long COVID | ↑ elevated | healthy controls | Neurological LC, brain fog | Lai et al. 2023 |
| ME/CFS | ↕ inconsistent | healthy controls | Cognitive dysfunction subset | Maksoud et al. 2023 |
| Migraine | ↕ inconsistent | healthy controls | — | Carta et al. 2025 |
| Multiple Sclerosis | ↑ elevated | MS relapse/disease activity vs healthy | — | Chitnis et al. 2025 |
| PACVS | ↑ elevated | healthy controls | Elevated sNfL in >30% of PACVS registry cohort | Mundorf et al. 2024 |
Frequently asked questions
In which conditions is Neurofilament Light Chain (NfL) altered?
In the OSMF atlas Neurofilament Light Chain (NfL) is reported in Alzheimer's Disease and Other Dementias, Epilepsy, Long COVID, ME/CFS, Migraine, Multiple Sclerosis, PACVS. It is elevated in 4, mixed in 3 across 7 entries.
Does Neurofilament Light Chain (NfL) point to one specific diagnosis?
No. Because Neurofilament Light Chain (NfL) changes in several conditions (Alzheimer's Disease and Other Dementias, Epilepsy, Long COVID, ME/CFS, Migraine, Multiple Sclerosis, PACVS), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.
What is the LOINC code for Neurofilament Light Chain (NfL)?
Entries in this atlas use LOINC 100996-8, 101281-4. LOINC codes identify the laboratory observation so results can be compared across systems.
Is one abnormal Neurofilament Light Chain (NfL) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.